wet- en regelgeving Novartis’ Lucentis secures European approval for infants with rare eye disease 9 september 2019InPharm.com
wet- en regelgeving FDA approves first drug to treat patients with rare lung condition 9 september 2019News-Medical.Net
wet- en regelgeving Keytruda scores EU approval in combination with Inlyta for first-line advanced renal cell carcinoma 5 september 2019InPharm.com
wet- en regelgeving Cancer drugs’ share of new FDA approvals doubled this decade thanks to smarter R&D: report 5 september 2019FiercePharma
wet- en regelgeving Roche’s Tecentriq combo becomes first EU-approved immunotherapy for triple-negative breast cancer 2 september 2019InPharm.com
wet- en regelgevingtechnologie 4WEB Medical gets US FDA marketing nod for cervical spine truss system-stand alone interbody fusion device 2 september 2019Pharma Biz